Ocrevus (Ocrelizumab) – Medicine for sclerosis
Ocrevus is a drug indicated for multiple sclerosis, from Roche’s laboratory.This drug is a monoclonal antibody produced synthetically in the laboratory, whose active substance is Ocrelizumab. This medicine consists of an injection that should be administered in the hospital, as it is necessary for the patient to be monitored for at least 1 hour after […]